As of close of business last night, T2 Biosystems Inc’s stock clocked out at $3.11, down -10.89% from its previous closing price of $3.49. In other words, the price has decreased by -$0.3800 from its previous closing price. On the day, 766398 shares were traded. TTOO stock price reached its highest trading level at $3.9500 during the session, while it also had its lowest trading level at $2.9900.
Ratios:
To gain a deeper understanding of TTOO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Alliance Global Partners on January 27, 2021, Downgraded its rating to Neutral and sets its target price to $2.40 from $2.60 previously.
On October 08, 2020, BTIG Research started tracking the stock assigning a Buy rating and target price of $2.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 28 ’23 when CR Group L.P. sold 7,148,945 shares for $0.16 per share. The transaction valued at 1,125,959 led to the insider holds 0 shares of the business.
CR Group L.P. sold 5,981,202 shares of TTOO for $1,145,998 on Sep 27 ’23. The 10% Owner now owns 571,796 shares after completing the transaction at $0.19 per share. On Sep 26 ’23, another insider, CR Group L.P., who serves as the 10% Owner of the company, sold 5,392,920 shares for $0.20 each. As a result, the insider received 1,082,359 and left with 1,050,192 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TTOO now has a Market Capitalization of 15.34M and an Enterprise Value of 40.50M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.39. Its current Enterprise Value per Revenue stands at 3.68 whereas that against EBITDA is -0.97.
Stock Price History:
Over the past 52 weeks, TTOO has reached a high of $70.00, while it has fallen to a 52-week low of $3.36. The 50-Day Moving Average of the stock is 4.7733, while the 200-Day Moving Average is calculated to be 12.6676.
Shares Statistics:
It appears that TTOO traded 347.22K shares on average per day over the past three months and 221.77k shares per day over the past ten days. Insiders hold about 38.19% of the company’s shares, while institutions hold 4.42% stake in the company. Shares short for TTOO as of Feb 29, 2024 were 316.38k with a Short Ratio of 0.91, compared to 322.97k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.81% and a Short% of Float of 8.87%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$2.2 for the current quarter, with a high estimate of -$2.2 and a low estimate of -$2.2, while EPS last year was -$141. The consensus estimate for the next quarter is -$2.27, with high estimates of -$2.27 and low estimates of -$2.27.
Analysts are recommending an EPS of between -$18.52 and -$18.52 for the fiscal current year, implying an average EPS of -$18.52. EPS for the following year is -$6.36, with 1 analysts recommending between -$6.36 and -$6.36.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $2M. It ranges from a high estimate of $2M to a low estimate of $2M. As of the current estimate, T2 Biosystems Inc’s year-ago sales were $5.48M, an estimated decrease of -63.50% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $2M, a decrease of -3.80% over than the figure of -$63.50% in the same quarter last year. There is a high estimate of $2M for the next quarter, whereas the lowest estimate is $2M.
A total of 1 analysts have provided revenue estimates for TTOO’s current fiscal year. The highest revenue estimate was $7M, while the lowest revenue estimate was $7M, resulting in an average revenue estimate of $7M. In the same quarter a year ago, actual revenue was $22.3M, down -68.60% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $10M in the next fiscal year. The high estimate is $10M and the low estimate is $10M. The average revenue growth estimate for next year is up 42.90% from the average revenue estimate for this year.
